Clik here to view.
China OKs ViewRay’s MRIdian radiation therapy device
ViewRay (NSDQ:VRAY) said today it won clearance from the China Food and Drug Administration for its MRIdian MRI-guided radiation therapy system. The MRIdian system is designed to integrate full-time MR...
View ArticleClik here to view.
Smith & Nephew touts Pico negative-pressure wound therapy in hip, knee surgeries
Smith & Nephew (NYSE:SNN) yesterday released results from a trial of its Pico negative-pressure wound therapy system used in orthopedic surgeries, touting reductions in wound exudate distributions,...
View ArticleClik here to view.
More evidence gastric bypass surgery leads to sustained weight loss
(Reuters) – Many people worry about regaining weight after getting gastric bypass surgery, a weight-loss procedure for very obese patients, but a new study suggests that most patients remain lighter 10...
View ArticleClik here to view.
Chrono Therapeutics closes $48m Series B for smart nicotine patch
Hayward, Calif.-based startup Chrono Therapeutics reportedly raised $47.6m in a Series B round, led by Kaiser Permanente Ventures. The money, Chrono CEO Alan Levy told Forbes, is to fund clinical...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for September 9, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
Evolent prices upsized $170m secondary offering
Evolent Health (NYSE:EVH) today released pricing for an upcoming secondary offering round, increasing the number of shares it is looking to float from 7 million to 7.5 million, now looking to bring in...
View ArticleClik here to view.
‘Botox Police’: FDA crime unit draws fire over import crackdown
(Reuters) – On April 5, 2012, a criminal investigator from the Food and Drug Administration named Robert West charged into an oncology clinic in Greenville, Tennessee. West was chasing a lead that Dr....
View ArticleClik here to view.
Early-stage ortho company Valeris Medical raises $1.5m
Early-stage orthopedic company Valeris Medical raised $1.5 million in a new round of debt financing, according to an SEC filing posted this week. Valeris “partners with strategic surgeon experts to...
View ArticleClik here to view.
Organovo launches bio-printed kidney tissue service
Organovo (PINK:ONVO), the contract research organization known for their 3D bio-printed liver tissue, announced today that it began commercial contracting for its second tissue service, the ExVive...
View ArticleClik here to view.
Apollo Endosurgery, Lpath ink reverse merger
Apollo Endosurgery and Lpath Inc. (NSDQ:LPTN) said yesterday that they inked a reverse merger agreement that will see Apollo’s owners become majority owners of the pharmaceutical company. Apollo plans...
View ArticleClik here to view.
FDA issues UDI compliance extension for certain Class II devices
By David Lennarz, Vice President and Co-Founder of Registrar Corp On September 6, 2016, the U.S. Food and Drug Administration (FDA) issued an extension to the Unique Device Identification (UDI)...
View ArticleClik here to view.
Sanofi, Google’s Verily launch $500m Onduo diabetes JV
Sanofi (NYSE:SNY) and Verily Life Sciences, the healthcare play owned by Google parent Alphabet (NSDQ:GOOGL), are launching a joint venture to tackle diabetes. The Cambridge, Mass.-based Onduo JV will...
View ArticleClik here to view.
Acelity CFO Casey departs on the eve of $1.75B debt offering, $450m refi
UPDATED Sept. 13, 2016, with details on Casey’s move to Lending Club. Acelity CFO Tom Casey is stepping down effective Sept. 16 for the chief finance spot at Lending Club, as Acelity prepares for a...
View ArticleClik here to view.
Teva plans competitor for Mylan’s EpiPen
Teva Pharmaceutical (NYSE:TEVA) said last week that it hopes to win U.S. approval for its version of Mylan‘s (NSDQ:MYL) EpiPen by late 2017 or early 2018. Mylan’s EpiPen holds an estimated 94% market...
View ArticleClik here to view.
Resonetics plans Minnesota laser micro-manufacturing plant
Resonetics said today it is opening a laser micro-manufacturing facility in Plymouth, Minn. Get the full story at our sister site, Medical Design & Outsourcing. The post Resonetics plans...
View ArticleClik here to view.
Appeals court overturns triple damages in Zimmer Biomet’s $280m patent loss...
A federal appeals court today overturned the enhanced damages and attorney fees awarded in Stryker‘s (NYSE:SYK) $70 million patent infringement win over Zimmer Biomet (NYSE:ZBH), but upheld its prior...
View ArticleClik here to view.
Terumo, CytoSorbents ink cardiac surgery deal
Terumo Corp. (TYO:4543) said today it inked a strategic partnership deal with CytoSorbents to commercialize its CytoSorb blood purification adsorber for cardiac surgery applications. New Jersey-based...
View ArticleClik here to view.
Private equity player Vance Street Capital acquires Motion Dynamics
Private equity player Vance Street Capital said it invested an unspecified amount in Motion Dynamics Corp. and its wire-based components business. Los Angeles-based Vance Street said Motion Dynamics is...
View ArticleClik here to view.
Biotronik touts dual drug-coated balloon-stent therapy for lower-limb disease
Biotronik today released data from studies of its Pulsar-18 bare metal self-expanding stent and Passeo-18 Lux drug-coated ballon, touting high rates or primary patency and freedom from target lesion...
View ArticleClik here to view.
AstraZeneca, Bespak ink deal for metered-dose inhaler
AstraZeneca (NYSE:AZN) said last week that it inked a multi-year commercial supply deal with Consort Medical (LON:CSRT) subsidiary Bespak for its pressurized metered-dose inhaler technology. Bespak...
View Article